SHMT1 and acute lymphoblastic leukemia: Indeed, the use of a dual inhibitor of SHMT1/2, SHIN2, was able to inhibit proliferation in vitro and exert anti-leukemic effects in vivo as a single agent in models of T-ALL (NOTCH1-driven T-ALL mouse models and patient-derived T-ALL xenografts).